Transcription of Public Assessment Report Repeat-Use Mutual …
{{id}} {{{paragraph}}}
Example: barber
Public Assessment Report Repeat-Use Mutual …
Public Assessment Report Repeat-Use Mutual recognition Procedure VERSATIS 5% MEDICATED PLASTER LIDOCAINE 5% MEDICATED PLASTER (Lidocaine) Procedure No: UK/H/1040-1041/001/E03 UK Licence No: PL 21727/0016-0017 Grunenthal Limited MRPAR Versatis/Lidocaine 5% Medicated Plaster UK/H/1040-1041/001/E03 2 LAY SUMMARY VERSATIS 5% MEDICATED PLASTER LIDOCAINE 5% MEDICATED PLASTER (lidocaine) This is a summary of the Public Assessment Report (PAR) for Versatis/Lidocaine 5% Medicated Plaster (PL 21727/0016-0017). It explains how Versatis/Lidocaine 5% Medicated Plaster w as assessed and its authorisation recommended, as well as its conditions of use. It is not intended to provide practical advice on how to use Versatis/Lidocaine 5% Medicated Plaster.
Public Assessment Report . Repeat-Use Mutual Recognition Procedure . VERSATIS 5% MEDICATED PLASTER . LIDOCAINE 5% MEDICATED PLASTER (Lidocaine) Procedure No: UK/H/1040-1041/001/E03
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Public Assessment Report Mutual Recognition, Public Assessment Report Mutual Recognition Procedure, Assessment of Periodic, Assessment of periodic safety, OECD REGULATORY, MUTUAL RECOGNITION, The Mutual Recognition and Decentralised Procedures, Justice in South Africa: Children, REPORT, Justice in South Africa: Children’s Rights Under Construction, WHO Drug Information, Out of Character, National Qualifications Framework